Holen Sie sich die Stockscreener-App
1.875
3.59%
0.065
Schlusskurs vom Vortag:
$1.81
Offen:
$1.85
24-Stunden-Volumen:
4,736
Relative Volume:
0.10
Marktkapitalisierung:
$42.16M
Einnahmen:
$35.16M
Nettoeinkommen (Verlust:
$-11.44M
KGV:
-3.1454
EPS:
-0.5961
Netto-Cashflow:
$-15.44M
1W Leistung:
-1.32%
1M Leistung:
-26.76%
6M Leistung:
-55.46%
1J Leistung:
-74.26%
1-Tages-Spanne:
$1.85
$1.93
1-Wochen-Bereich:
$1.80
$2.0493
52-Wochen-Spanne:
$1.80
$12.80
Bioharvest Sciences Inc Stock (BHST) Company Profile
Firmenname
Bioharvest Sciences Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare BHST vs JBS, KHC, GIS, MKC, SJM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
1.86 | 41.03M | 35.16M | -11.44M | -15.44M | -0.5961 |
JBS
Jbs Nv
|
12.78 | 42.33B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
24.73 | 29.53B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
37.23 | 20.15B | 18.42B | -85.30M | 1.63B | -0.1894 |
MKC
Mccormick Co Inc
|
51.49 | 13.95B | 7.39B | 1.63B | 1.02B | 6.0085 |
SJM
J M Smucker Co
|
124.11 | 13.32B | 9.05B | -138.70M | 1.16B | -1.307 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Roth Capital | Buy |
| 2025-05-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-12-18 | Eingeleitet | Maxim Group | Buy |
Bioharvest Sciences Inc Aktie (BHST) Neueste Nachrichten
BioHarvest Sciences Inc. (NASDAQ: BHST) to Initiate Dual Listing on Tel Aviv Stock Exchange for 22.7M Shares - Kalkine Media
Tel Aviv listing on deck for BioHarvest (NASDAQ: BHST). Trading is expected to start in 2026. - Stock Titan
Small cap wrap: Tiziana Life Sciences, Thistle Resources, Alvopetro, BioHarvest... - Proactive financial news
BioHarvest Sciences to dual-list shares on Tel Aviv exchange By Investing.com - Investing.com Nigeria
BioHarvest Sciences plans Tel Aviv Stock Exchange dual listing - Yahoo Finance
BioHarvest Sciences to dual-list shares on Tel Aviv exchange - Investing.com
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) - marketscreener.com
BioHarvest Sciences Inc.'s Growth Strategy Progress Update #3 Live Video Conference November 19, 2020 @ 2:00pm E.S.T - TMX Newsfile
BioHarvest Sciences: Patented plant cell culture platform drives scalable growth and strong revenue outlook - TradingView
BioHarvest (BHST) Daily Price Brief: Finishes 2.76% Down at $2.11 at the Close; Session Range View: Price Remains Between $2.00 Support and $2.22 Resistance in Latest TradingLow Volatility Picks - vinanet.vn
BioHarvest (BHST) Earnings Recap: The Available Earnings Metric Delivers a Miss in the Reported Period; The Stock Loses 1.15% in the Available RecordEarnings Manipulation Risk - vinanet.vn
symbol__ Stock Quote Price and Forecast - CNN
BHST Looks 70.0% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
BioHarvest Sciences Inc. Common Stock (NASDAQ: BHST) Stock Price, News & Analysis - Kalkine
BHST Q1 2025 Earnings: Wider-Than-Expected Loss Sends Shares DownEarnings Trend Analysis - vinanet.vn
BioHarvest Sciences Inc. (NASDAQ:BHST) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
BHST Maintains Rating by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
BioHarvest Sciences Inc. (BHST) Jumps 6%: Breaking Toward Resistance at $2.31Gap Down Bounce Plays - Vinanet
BHST Maintained by Roth Capital -- Price Target Lowered to $8.00 - GuruFocus
BioHarvest at canaccord growth conference: scaling plant-cell platform By Investing.com - Investing.com Canada
BioHarvest Sciences: Patented cell culture platform secures $20–30M fragrance deal, targets $40M revenue and profitability - TradingView
BioHarvest at canaccord growth conference: scaling plant-cell platform - Investing.com
BioHarvest Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Maxim Group Maintains BioHarvest Sciences(BHST.US) With Buy Rating, Maintains Target Price $5 - Moomoo
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript - AOL.com
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlight - GuruFocus
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... - Yahoo Finance
What Could BioHarvest Sciences (NASDAQ:BHST) Quarterly Update Show? - Kalkine Media
What Will BioHarvest Sciences (NASDAQ:BHST) Add to Nasdaq Focus? - Kalkine Media
BioHarvest Sciences Inc. Common Stock Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss By Investing.com - Investing.com Canada
What Is BioHarvest Sciences (NASDAQ:BHST) Nasdaq Composite Focus? - kalkinemedia.com
BioHarvest Sciences cuts FY26 sales guidance to $37-40 million - scanx.trade
Transcript : BioHarvest Sciences Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
BioHarvest Sciences Q2 Earnings Call Highlights - marketbeat.com
BioHarvest Sciences: Secured first major CDMO contract and reaffirmed 2027 EBITDA breakeven despite revised 2026 guidance - TradingView
BioHarvest Sciences: Secured a transformative fragrance CDMO contract, driving revenue growth and 2027 EBITDA breakeven - TradingView
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss - Investing.com
BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound - finance.yahoo.com
BioHarvest Sciences shares surge 11% after major fragrance manufacturing deal - Yahoo Finance
BioHarvest Sciences shares surge 11% on major fragrance deal By Investing.com - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
BioHarvest secures fragrance manufacturing deal worth $20-30M By Investing.com - Investing.com Australia
BioHarvest secures first CDMO manufacturing dea... - pluang.com
BioHarvest Sciences shares surge 11% on major fragrance deal - Investing.com
BioHarvest Sciences: Q2 revenue up 3.8% to $8.8M; first CDMO deal signed; full-year guidance revised downward - TradingView
BioHarvest secures fragrance manufacturing deal worth $20-30M - Investing.com
BioHarvest Sciences Reports Q2 2026 Results, Secures First CDMO Fragrance Manufacturing Agreement for 20-Ton Production Program - kalkine.ca
BioHarvest inks exclusive deal to produce rare luxury fragrance, targeting $20-$30M revenue by 2027. - Pluang
BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Finanzdaten der Bioharvest Sciences Inc-Aktie (BHST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):